Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
1.
Nat Commun ; 14(1): 7726, 2023 Nov 25.
Article de Anglais | MEDLINE | ID: mdl-38001069

RÉSUMÉ

Clinical immunity against Plasmodium falciparum infection develops in residents of malaria endemic regions, manifesting in reduced clinical symptoms during infection and in protection against severe disease but the mechanisms are not fully understood. Here, we compare the cellular and humoral immune response of clinically immune (0-1 episode over 18 months) and susceptible (at least 3 episodes) during a mild episode of Pf malaria infection in a malaria endemic region of Malawi, by analysing peripheral blood samples using high dimensional mass cytometry (CyTOF), spectral flow cytometry and single-cell transcriptomic analyses. In the clinically immune, we find increased proportions of circulating follicular helper T cells and classical monocytes, while the humoral immune response shows characteristic age-related differences in the protected. Presence of memory CD4+ T cell clones with a strong cytolytic ZEB2+ T helper 1 effector signature, sharing identical T cell receptor clonotypes and recognizing the Pf-derived circumsporozoite protein (CSP) antigen are found in the blood of the Pf-infected participants gaining protection. Moreover, in clinically protected participants, ZEB2+ memory CD4+ T cells express lower level of inhibitory and chemotactic receptors. We thus propose that clonally expanded ZEB2+ CSP-specific cytolytic memory CD4+ Th1 cells may contribute to clinical immunity against the sporozoite and liver-stage Pf malaria.


Sujet(s)
Vaccins contre le paludisme , Paludisme à Plasmodium falciparum , Paludisme , Humains , Plasmodium falciparum , Paludisme à Plasmodium falciparum/prévention et contrôle , Paludisme/prévention et contrôle , Lymphocytes auxiliaires Th1 , Protéines de protozoaire , Clones cellulaires
2.
mSystems ; 7(5): e0044222, 2022 10 26.
Article de Anglais | MEDLINE | ID: mdl-36121169

RÉSUMÉ

Shigella continues to be a major contributor to diarrheal illness and dysentery in children younger than 5 years of age in low- and middle-income countries. Strategies for the prevention of shigellosis have focused on enhancing adaptive immunity. The interaction between Shigella and intrinsic host factors, such as the microbiome, remains unknown. We hypothesized that Shigella infection would impact the developing microbial community in infancy and, conversely, that changes in the gastrointestinal microbiome may predispose infections. To test this hypothesis, we characterized the gastrointestinal microbiota in a longitudinal birth cohort from Malawi that was monitored for Shigella infection using 16S rRNA amplicon sequencing. Children with at least one Shigella quantitative polymerase chain reaction (qPCR) positive sample during the first 2 years of life (cases) were compared to uninfected controls that were matched for sex and age. Overall, the microbial species diversity, as measured by the Shannon diversity index, increased over time, regardless of case status. At early time points, the microbial community was dominated by Bifidobacterium longum and Escherichia/Shigella. A greater abundance of Prevotella 9 and Bifidobacterium kashiwanohense was observed at 2 years of age. While no single species was associated with susceptibility to Shigella infection, significant increases in Lachnospiraceae NK4A136 and Fusicatenibacter saccharivorans were observed following Shigella infection. Both taxa are in the family Lachnospiraceae, which are known short-chain fatty acid producers that may improve gut health. Our findings identified temporal changes in the gastrointestinal microbiota associated with Shigella infection in Malawian children and highlight the need to further elucidate the microbial communities associated with disease susceptibility and resolution. IMPORTANCE Shigella causes more than 180 million cases of diarrhea globally, mostly in children living in poor regions. Infection can lead to severe health impairments that reduce quality of life. There is increasing evidence that disruptions in the gut microbiome early in life can influence susceptibility to illnesses. A delayed or impaired reconstitution of the microbiota following infection can further impact overall health. Aiming to improve our understanding of the interaction between Shigella and the developing infant microbiome, we investigated changes in the gut microbiome of Shigella-infected and uninfected children over the course of their first 2 years of life. We identified species that may be involved in recovery from Shigella infection and in driving the microbiota back to homeostasis. These findings support future studies into the elucidation of the interaction between the microbiota and enteric pathogens in young children and into the identification of potential targets for prevention or treatment.


Sujet(s)
Dysenterie bacillaire , Microbiome gastro-intestinal , Shigella , Nourrisson , Humains , Enfant , Enfant d'âge préscolaire , Microbiome gastro-intestinal/génétique , Dysenterie bacillaire/épidémiologie , ARN ribosomique 16S/génétique , Qualité de vie , Fèces/microbiologie , Shigella/génétique , Diarrhée/microbiologie
3.
AIDS ; 21(13): 1723-30, 2007 Aug 20.
Article de Anglais | MEDLINE | ID: mdl-17690570

RÉSUMÉ

OBJECTIVES: This study was conducted to compare viral dynamics in blood and semen between subjects with antibody negative, acute HIV-1 infection and other subjects with later stages of infection. DESIGN: A prospective cohort study was embedded within a cross-sectional study of HIV screening in a Lilongwe, Malawi STD clinic. METHODS: Blood samples from HIV antibody negative or indeterminate volunteers were used to detect HIV RNA in plasma using a pooling strategy. Blood and seminal plasma HIV-1 RNA concentrations were measured over 16 weeks. RESULTS: Sixteen men with acute HIV infection and 25 men with chronic HIV infection were studied. Blood viral load in subjects with acute HIV infection was highest about 17 days after infection (mean +/- SE, 6.9 +/- 0.5 log10 copies/ml), while semen viral load peaked about 30 days after infection (4.5 +/- 0.4 log10 copies/ml). Semen viral load declined by 1.7 log10 to a nadir by week 10 of HIV infection. Semen and blood viral loads were more stable in chronically infected subjects over 16 weeks. Higher semen levels of HIV RNA were noted in subjects with low CD4 cell counts. CONCLUSIONS: These results provide a biological explanation for reported increases in HIV transmission during the very early (acute) and late stages of infection. Recognizing temporal differences in HIV shedding in the genital tract is important in the development of effective HIV prevention strategies.


Sujet(s)
Infections à VIH/virologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/isolement et purification , Sperme/virologie , Maladie aigüe , Adolescent , Adulte , Maladie chronique , Évolution de la maladie , Méthodes épidémiologiques , Infections à VIH/transmission , Humains , Mâle , Adulte d'âge moyen , ARN viral/analyse , ARN viral/sang , Charge virale , Virémie/virologie , Excrétion virale
4.
J Infect Dis ; 195(9): 1278-82, 2007 May 01.
Article de Anglais | MEDLINE | ID: mdl-17396996

RÉSUMÉ

We measured enteric parasitic infection prevalence and the effect of treatment on human immunodeficiency virus (HIV) RNA levels to assess their importance to HIV primary care in resource-limited settings. Adults in Lilongwe, Malawi, were evaluated, treated, and followed-up for parasitic and HIV infections. Of 389 patients, 266 (68%) were HIV infected. Helminth infections were more common in HIV-uninfected than in HIV-infected patients (39% vs. 17%). Among HIV-infected patients, helminth infections were associated with higher CD4 cell counts but not with higher HIV RNA levels. Successful treatment of parasitic infections had no effect on HIV RNA levels. Although common, parasitic infections did not impact HIV RNA levels.


Sujet(s)
Infections à VIH/épidémiologie , Infections à VIH/virologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/isolement et purification , Helminthiase/épidémiologie , Parasitoses intestinales/épidémiologie , Adulte , Albendazole/administration et posologie , Albendazole/usage thérapeutique , Soins ambulatoires , Anthelminthiques/administration et posologie , Anthelminthiques/usage thérapeutique , Antiprotozoaires/administration et posologie , Antiprotozoaires/usage thérapeutique , Numération des lymphocytes CD4 , Fèces/parasitologie , Femelle , Infections à VIH/sang , Infections à VIH/complications , Infections à VIH/traitement médicamenteux , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Helminthiase/sang , Helminthiase/complications , Helminthiase/traitement médicamenteux , Helminthiase/parasitologie , Helminthiase/urine , Humains , Parasitoses intestinales/sang , Parasitoses intestinales/complications , Parasitoses intestinales/traitement médicamenteux , Parasitoses intestinales/parasitologie , Parasitoses intestinales/urine , Malawi/épidémiologie , Mâle , Zone médicalement sous-équipée , Métronidazole/administration et posologie , Métronidazole/usage thérapeutique , Praziquantel/administration et posologie , Praziquantel/usage thérapeutique , ARN viral/analyse , Charge virale , Excrétion virale
5.
J Infect Dis ; 195(3): 416-24, 2007 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-17205481

RÉSUMÉ

BACKGROUND: We conducted a prospective study to evaluate methods of detecting clients with sexually transmitted diseases (STDs) who were acutely coinfected with human immunodeficiency virus (HIV) in Lilongwe, Malawi. METHODS: After informed consent was obtained, all clients with acute STDs were offered voluntary HIV counseling and testing by 2 rapid antibody tests. Samples from rapid test-negative or -discordant subjects were pooled (50 : 5 : 1) and tested for HIV RNA. Western blots were performed on all rapid test-discordant specimens with detectable HIV RNA. A subset of specimens received p24 antigen testing with standard and/or ultrasensitive methods. Patients with possible acute HIV infection were followed to confirm seroconversion. RESULTS: A total of 1450 clients (34% female and 66% male) agreed to testing, of whom 588 (40.55%) had established HIV infection and 21 (1.45%) had acute infection. Discordant rapid antibody tests identified 7 of 21 (33.3% sensitivity), standard p24 antigen identified 12 of 16 (75% sensitivity), and ultrasensitive p24 antigen identified 15 of 17 (88% sensitivity) acute cases. By definition, the sensitivity of the RNA assay was 100%. CONCLUSIONS: Real-time pooled RNA testing for the detection of acute HIV infection is feasible in resource-limited settings. However, parallel rapid testing and p24 antigen testing are technologically simpler and together may detect approximately 90% of acute cases.


Sujet(s)
Infections à VIH/diagnostic , VIH (Virus de l'Immunodéficience Humaine) , Maladie aigüe , Adulte , Technique de Western , Études de faisabilité , Femelle , VIH (Virus de l'Immunodéficience Humaine)/génétique , VIH (Virus de l'Immunodéficience Humaine)/isolement et purification , Anticorps anti-VIH/sang , Protéine de capside p24 du VIH/sang , Infections à VIH/sang , Infections à VIH/prévention et contrôle , Humains , Malawi , Mâle , Études prospectives , ARN viral/sang , Trousses de réactifs pour diagnostic , Sensibilité et spécificité
6.
J Infect Dis ; 189(10): 1926-31, 2004 May 15.
Article de Anglais | MEDLINE | ID: mdl-15122531

RÉSUMÉ

Variations in estimates of prevalence of trichomoniasis in men may reflect true differences in the burden of disease but are also affected by the performance of diagnostic methods and the type of specimen tested. In this study, men were evaluated at baseline and at follow-up, to evaluate syndromic management of urethritis and the effects of human immunodeficiency virus and trichomoniasis, in Lilongwe, Malawi. First-void urine specimens and urethral swabs were obtained at enrollment, for Trichomonas vaginalis culture; semen specimens were also obtained at follow-up. The sensitivities of testing methods using urine specimens and urethral swabs were equal; 67% of cases were identified by use of either specimen, and, in 47% of cases, both specimens tested positive. When semen specimens were included, all 3 specimens tested positive in only 19% of cases. Semen was the most sensitive single specimen, and, in 25.6% of cases, only semen specimens tested positive. Thus, prevalence of T. vaginalis infection in men is underestimated if only 1 specimen is tested.


Sujet(s)
Sperme/microbiologie , Trichomonase/diagnostic , Trichomonas vaginalis/isolement et purification , Urètre/microbiologie , Adolescent , Adulte , Animaux , Antiprotozoaires/usage thérapeutique , Infections à VIH/complications , Humains , Modèles logistiques , Études longitudinales , Malawi/épidémiologie , Mâle , Métronidazole/usage thérapeutique , Adulte d'âge moyen , Prévalence , Sensibilité et spécificité , Trichomonase/traitement médicamenteux , Trichomonase/épidémiologie , Trichomonase/urine , Urétrite/complications , Urétrite/traitement médicamenteux , Urétrite/microbiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...